ConductScience.org, home

Paper8902255

Cyclandelate in the prophylaxis of migraine: a randomized, parallel, double-blind study in comparison with placebo and propranolol. The Study group.

Diener HC and 8 others. Cephalalgia, 1996. Cited by 42 papers, by iCite.

Cite this record

ConductScience Library. Cyclandelate in the prophylaxis of migraine: a randomized, parallel, double-blind study in comparison with placebo and propranolol. The Study group. Papers, record 8902255. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8902255

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Cyclandelate in the prophylaxis of migraine: a randomized, parallel, double-blind study in comparison with placebo and propranolol. The Study group.
PubMed
Journal
Cephalalgia
PubMed
Year
1996
PubMed
Publication types
Clinical Trial, Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial
PubMed
Citations, by iCite
42
iCite
Relative citation ratio, by iCite
1.72
iCite
Revised in PubMed
2017-02-14
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Diener HCH C
2Föh MM
3Iaccarino CC
4Wessely PP
5Isler HH
6Strenge HH
7Fischer MM
8Wedekind WW
9Taneri ZZ

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CyclandelateMajor topic
Migraine DisordersMajor topic
PropranololMajor topic
Vasodilator AgentsMajor topic
Adult
Dose-Response Relationship, Drug
Double-Blind Method
Drug Administration Schedule
Female
Humans
Male
Middle Aged
Pain Measurement
Treatment Outcome

Source PubMed

Download CSV of topics

Cited by17

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 42 citations.

PMIDTitleJournalYearIn PapersSource
40978493Oral preventive medications for migraine in adults aged 18-65: a network meta-analysis.Front Pharmacol2025https://conductscience.org/library/papers/40978493PubMed
39044170European Headache Federation (EHF) critical re-appraisal and meta-analysis of oral drugs in migraine prevention - part 4: propranolol.J Headache Pain2024https://conductscience.org/library/papers/39044170PubMed
38110000High Dosage Omega-3 Fatty Acids Outperform Existing Pharmacological Options for Migraine Prophylaxis: A Network Meta-Analysis.Adv Nutr2024https://conductscience.org/library/papers/38110000PubMed
37208596The comparative effectiveness of migraine preventive drugs: a systematic review and network meta-analysis.J Headache Pain2023https://conductscience.org/library/papers/37208596PubMed
37193973The temporal trend of placebo response in migraine prevention from 1990 to 2021: a systematic literature review and meta-analysis with regression.J Headache Pain2023https://conductscience.org/library/papers/37193973PubMed
34696711CGRP monoclonal antibodies in migraine: an efficacy and tolerability comparison with standard prophylactic drugs.J Headache Pain2021https://conductscience.org/library/papers/34696711PubMed
30893319Beta-blockers for the prevention of headache in adults, a systematic review and meta-analysis.PLoS One2019https://conductscience.org/library/papers/30893319PubMed
28220376Unveiling the relative efficacy, safety and tolerability of prophylactic medications for migraine: pairwise and network-meta analysis.J Headache Pain2017https://conductscience.org/library/papers/28220376PubMed
28212466WITHDRAWN: Propranolol for migraine prophylaxis.Cochrane Database Syst Rev2017https://conductscience.org/library/papers/28212466PubMed
26839703Evidence-Based Treatments for Adults with Migraine.Pain Res Treat2015https://conductscience.org/library/papers/26839703PubMed
26172390A Comparative Effectiveness Meta-Analysis of Drugs for the Prophylaxis of Migraine Headache.PLoS One2015https://conductscience.org/library/papers/26172390PubMed
20880898Effect of preventive (beta blocker) treatment, behavioural migraine management, or their combination on outcomes of optimised acute treatment in frequent migraine: randomised controlled trial.BMJ2010https://conductscience.org/library/papers/20880898PubMed
20169042Topiramate in the prevention and treatment of migraine: efficacy, safety and patient preference.Neuropsychiatr Dis Treat2010https://conductscience.org/library/papers/20169042PubMed
19209286Optimizing prophylactic treatment of migraine: Subtypes and patient matching.Ther Clin Risk Manag2008https://conductscience.org/library/papers/19209286PubMed
18806984[Alternatives to beta blockers in preventive migraine treatment].Nervenarzt2008https://conductscience.org/library/papers/18806984PubMed
15581385The PROMISE study: PROphylaxis of MIgraine with SEglor (dihydroergotamine mesilate) in French primary care.CNS Drugs2004https://conductscience.org/library/papers/15581385PubMed
9829155A practical guide to the management and prevention of migraine.Drugs1998https://conductscience.org/library/papers/9829155PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
F22147PubTator's text mininghttps://conductscience.org/library/genes/2147

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8902255

GET https://conductscience.org/api/papers/v1/8902255/authors